@FiercePharma: Another German drugmaker in takeover talks: Riemser may pick shortlist by next week--Bloomberg. Story | Follow @FiercePharma
> GlaxoSmithKline ($GSK) may avoid buying "lemons" by choosing from among its collaborators for buyouts, analysts tell Bloomberg. More
> Failing to unload its Loughborough, England, site to a life sciences buyer, AstraZeneca ($AZN) sold the property to the plastics recycler Jayplas. Article
> APP Pharmaceuticals nabbed three injectable generic products from Nexus Pharmaceuticals, including a copycat version of the UCB seizure drug Keppra. Item
> Danish pharma Lundbeck said it would launch an American Depositary Receipt via Deutsche Bank with ADRs trading on the U.S. over-the-counter market. Story
> Moody's hiked its credit rating on Mylan ($MYL), citing expectations for strong sales growth; its Ba1 rating is still below investment grade. News
> The Bristol-Myers Squibb Foundation said it would spend $15 million over 5 years to expand its Together on Diabetes initiative in China and India. Report
Biotech News
@FierceBiotech: Vitamin D boosts TB shot as cancer therapy. More | Follow @FierceBiotech
@RyanMFierce: Pfizer brings Lipitor brand to mobile app stores. Report | Follow @RyanMFierce
@JohnCFierce: So Globe's verastem coverage says best-case scenario is start trials in a year, products available in four. A three-year cancer stem cell program? Ha. | Follow @JohnCFierce
> J&J loses key FDA panel vote on Xarelto. Item
> European pharmas join forces on $285M antibiotics collaboration. News
> Sanofi chief highlights high hopes for liver cancer drug. Story
> Upstart biotech lures Vertex founder out of retirement. Report
Medical Device News
@FierceMedDev: HeartWare gained expanded European approval for its HVAD implant. Trials continue in the U.S., however. Story | Follow @FierceMedDev
@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
> Orrin Hatch pulls device tax repeal amendment from user fee bill. Report
> Once spectrum is approved, wireless patient monitors still face obstacles. Article
> Alere recalls thousands of cardiac diagnostic tests. More
> House Republicans push for tax-repeal vote. Item
Pharma Manufacturing News
@EricPFierce: FDA to Crescendo: We told you so. Marshals seize steroid gel from California firm that was selling unapproved drug. Report | Follow @EricPFierce
> FDA may impose more QA checks on heparin makers. Story
> Recipharm snags $114 million loan, says its shopping. Article
> Heart attack test alert from Alere. More
> FDA takes aim at Spanish drugmaker. Item
CRO News
@NesaNFierce: What should a CDMO do with 90 million Euros? Buy more CDMOs, as Recipharm announced it will do. Article | Follow @NesaNFierce
> SGS picks up testing company Vitrology for an undisclosed fee. News
> Pfizer's David Simmons joins PPD as new CEO and chairman. Story
> PRA expands European ops with new Dutch and British offices. More
> Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement. Item
Vaccines News
> Wishing you a happy HIV Vaccine Awareness Day. Report
> Vitamin D boosts TB shot as cancer therapy. Article
> DNA vaccine swats TB and HIV. News
> HIV vaccine carries its own adjuvant into clinical trials. Story
And Finally... Fever during pregnancy doubles the risk of autism or developmental delay, a new study finds. Report